Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
NDENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA)

NASDAQ Capital Market · Currency in USD
$4.80 ▲ +0.02 (+0.42%)
At close: Oct 23, 4:00 PM ET. Market closed.
$4.70 ▼ -0.10 (-2.08%)
After hours: Oct 23, 5:25 PM ET

Summary

Previous Close
$4.78
Open
$4.54
Day's Range
$4.54 – $4.80
52 Week Range
$2.96 – $6.95
Volume
4,502
Avg. Volume
37,343
Market Cap
$7.20M
Beta (5Y Monthly)
-0.07
PE Ratio (TTM)
--
EPS (TTM)
-$4.47
Earnings Date
Nov 13, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: ENDRA Life Sciences Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
10
CEO
Alexander Y. Tokman

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion.

Earnings

Next report: Fri, Nov 13, 2026
EPS estimate -$0.84 · Revenue est. $100.00K
DateEst.Actual
Aug 14, 2026-$0.84-$0.63Beat
May 18, 2026-$1.23-$1.09Beat
Mar 31, 2026-$1.23-$3.26Miss
Nov 14, 2025-$1.95-$1.75Beat
Aug 14, 2025-$2.27-$1.71Beat
May 15, 2025-$3.91-$2.59Beat

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on NDRA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.